| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |